European Journal of Internal Medicine
Volume 19, Issue 8 , Pages 575-578, December 2008

Systemic polyarteritis nodosa following hepatitis B vaccination

  • Jozélio Freire de Carvalho

      Affiliations

    • Rheumatology Division, São Paulo University School of Medicine, São Paulo, Brazil
    • Department of Internal Medicine B, Center for Autoimmune Diseases, affiliated with Tel-Aviv University Sackler Faculty of Medicine, Sheba Medical Center, Tel-Hashomer, Israel
    • JF Carvalho is a recipient of grant no. BEX 2367/06-8 awarded by CAPES.
  • ,
  • Rosa Maria Rodrigues Pereira

      Affiliations

    • Rheumatology Division, São Paulo University School of Medicine, São Paulo, Brazil
  • ,
  • Yehuda Shoenfeld

      Affiliations

    • Department of Internal Medicine B, Center for Autoimmune Diseases, affiliated with Tel-Aviv University Sackler Faculty of Medicine, Sheba Medical Center, Tel-Hashomer, Israel
    • Corresponding Author InformationCorresponding author. Department of Medicine B and Center for Autoimmune Diseases, The Chaim Sheba Medical Center, Tel-Hashomer, 52621, Israel. Tel.: +972 3 5302652; fax: +972 3 5352855.
    • Recipient of the Laura Schwarz-Kipp Chair for Research of Autoimmune Diseases, Tel-Aviv University.

Received 22 February 2007; received in revised form 22 June 2007; accepted 28 June 2007. published online 23 April 2008.

Abstract 

The authors report a patient who developed systemic polyarteritis nodosa two months after hepatitis B vaccination and review the literature concerning this vaccination and the development of autoimmune conditions, mainly vasculitis. A 14-year-old boy who had no relevant previous history and who was not taking any drugs presented with a livedo reticularis, fever, loss of weight, testicular pain, and paresthesias two months after receiving the third dose of a hepatitis B vaccination. Inflammatory parameters (ESR and CRP) were high. The patient met the ACR diagnostic criteria for polyarteritis nodosa. He received corticosteroids and immunosuppressants and showed improvement. After reviewing the 27 cases of vasculitis after hepatitis B vaccination reported in the current literature, the authors suggest that, in some cases, vaccination may be the triggering factor for vasculitis in individuals with a genetic predisposition. Physicians should be aware of this possible association.

Keywords: Vaccination, Vaccine, Hepatitis B, Hepatitis B vaccination, Vasculitis, Polyarteritis nodosa

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

PII: S0953-6205(08)00077-0

doi:10.1016/j.ejim.2007.06.035

European Journal of Internal Medicine
Volume 19, Issue 8 , Pages 575-578, December 2008